The American College of Cardiology has
jotted down some advanced technologies like wearable technologies, possible
changes to stenting practices, state legislation on energy drinks, expanded use
of minimally invasive heart repair procedures, and the development of a new
class of cholesterol lowering drugs that would make news in 2015.
Wearable technologies to monitor a
person's health outside their physician's office would play an increasing role
in health care as these devices can measure pulse rate and use sensors to track
length and type of exercise.
An approach of risks, benefits, and
timing of complete revascularization after a heart attack would involve the
practice of inserting stents in multiple arteries.
Recommendations are there for young
athletes for eligibility and temporary or permanent disqualification of
athletes with heart conditions from participation in competitive sports. It
also discusses the use of performance-enhancing substances and dietary
supplements, diagnostic testing strategies, legal considerations and other
topics.
An alternative to open heart surgery,
transcatheter aortic valve replacement, has been available in the United States
for inoperable patients. So far, these new heart repair options are only
available for high risk patients, including those considered too frail for
surgery.
Food and Drug Administration was
expected to make a decision on whether to approve edoxaban, as this would be
the fourth drug on the market as an alternative to warfarin, which for decades
was widely prescribed for patients to prevent strokes due to atrial
fibrillation.
PCSK9 inhibitors, a new class of
cholesterol-lowering medications that would dramatically lower levels of
low-density lipoprotein (LDL), known as "bad" cholesterol, especially
in patients with unusually high blood cholesterol levels that don't respond to
other treatments.
Research has shown that comprehensive,
exercise-based cardiac rehabilitation reduces mortality rates in patients after
myocardial infarction. Diet and physical activity both prevent and help treat
many established atherosclerotic risk factors, including elevated blood
pressure, insulin resistance and glucose intolerance, elevated triglyceride
concentrations, and obesity.
Team-based care continues to grow; state
legislatures are likely to weigh in on issues of training adequacy,
reimbursement, and patient safety, as it fosters collaboration and leverage
each team member's unique skills, knowledge and training.
Legislation is likely to emerge the
growing abuse of energy drinks among children and scholastic athletes, at a
state level. Many medical communities believe that the increased number of
children who visit their offices and emergency rooms after consuming energy
drinks merits changes in public policy aimed at reducing consumption by
minors.
Researchers has made a lot of new
cardiac technologies that will help treat the patients better in the coming
2015.
The American College of Cardiology has
jotted down some advanced technologies like wearable technologies, possible
changes to stenting practices, state legislation on energy drinks, expanded use
of minimally invasive heart repair procedures, and the development of a new
class of cholesterol lowering drugs that would make news in 2015.
Wearable technologies to monitor a
person's health outside their physician's office would play an increasing role
in health care as these devices can measure pulse rate and use sensors to track
length and type of exercise.
An approach of risks, benefits, and
timing of complete revascularization after a heart attack would involve the
practice of inserting stents in multiple arteries.
Recommendations are there for young athletes
for eligibility and temporary or permanent disqualification of athletes with
heart conditions from participation in competitive sports. It also discusses
the use of performance-enhancing substances and dietary supplements, diagnostic
testing strategies, legal considerations and other topics.
An alternative to open heart surgery,
transcatheter aortic valve replacement, has been available in the United States
for inoperable patients. So far, these new heart repair options are only
available for high risk patients, including those considered too frail for
surgery.
Food and Drug Administration was
expected to make a decision on whether to approve edoxaban, as this would be
the fourth drug on the market as an alternative to warfarin, which for decades
was widely prescribed for patients to prevent strokes due to atrial
fibrillation.
PCSK9 inhibitors, a new class of
cholesterol-lowering medications that would dramatically lower levels of
low-density lipoprotein (LDL), known as "bad" cholesterol, especially
in patients with unusually high blood cholesterol levels that don't respond to
other treatments.
Research has shown that comprehensive,
exercise-based cardiac rehabilitation reduces mortality rates in patients after
myocardial infarction. Diet and physical activity both prevent and help treat
many established atherosclerotic risk factors, including elevated blood
pressure, insulin resistance and glucose intolerance, elevated triglyceride
concentrations, and obesity.
Team-based care continues to grow; state
legislatures are likely to weigh in on issues of training adequacy,
reimbursement, and patient safety, as it fosters collaboration and leverage
each team member's unique skills, knowledge and training.
Legislation is likely to emerge the
growing abuse of energy drinks among children and scholastic athletes, at a
state level. Many medical communities believe that the increased number of
children who visit their offices and emergency rooms after consuming energy
drinks merits changes in public policy aimed at reducing consumption by minors.
